It was observed that the patterns are similar in all the subtypes as observed in the overall cohort except that the patients who received chemotherapy for the locoregional BC were higher in the Q5 when compared to the Q1 in both TNBC and HER2 + BCs. Here, ERBB2 is linked to breast cancer.